Isoxazolines as inhibitors of fatty acid amide hydrolase

Details for Australian Patent Application No. 2010249674 (hide)

Owner Infinity Pharmaceuticals, Inc.

Inventors Behnke, Mark L.; Castro, Alfredo C.; Chan, Lawrence K.; Evans, Catherine A.; Grenier, Louis; Grogan, Michael J.; Leblanc, Yves; Liu, Tao; Peluso, Stephane; Snyder, Daniel A.; Tibbitts, Thomas T.

Agent Henry Hughes Ltd

Pub. Number AU-A-2010249674

PCT Pub. Number WO2010/135360

Priority 61/179,285 18.05.09 US; 61/179,283 18.05.09 US; 61/179,280 18.05.09 US

Filing date 18 May 2010

Wipo publication date 25 November 2010

International Classifications

C07D 261/02 (2006.01) Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms

Event Publications

15 December 2011 PCT application entered the National Phase

  PCT publication WO2010/135360 Priority application(s): WO2010/135360

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010249678-Multi-directional microfluidic devices and methods

2010249670-Bioprocessing